Skip to content
Founder & CEO of Empiriko
Senior Partner, Technology Companies & Life Sciences Group at Goodwin
Chairman and CEO of Xontogeny
Immediate Past Chair
Co-founder, President and Chief Executive Officer of Frequency Therapeutics
SVP, General Counsel and Secretary of Alnylam Pharmaceuticals, Inc.
President & Chief Executive Officer, Waters Corporation
President & CEO of Anika Therapeutics, Inc.
Chief Business Officer & US President, Citrine Medicine
President, and EVP of R&D, of Xilio Therapeutics
President and Chief Executive Officer, Genocea Biosciences, Inc.
Vice President, Discovery Biotherapeutics, Bristol Myers Squibb
Chief Legal Officer of Bluebird Bio
Managing Director, Life Sciences, JLL
Director at Broadview Ventures
Vice President, Research, Amgen
President and CEO at Organogenesis Inc.
Principal, RMG Associates
Managing Partner, Binney Street Capital | Dana Farber
Chief Science Officer, Danaher Corporation
President of Pericor Science, Inc.
Chief Investor Relations and Communications Officer, Section 32 Ventures
Managing Director, Boehringer Ingelheim Venture Fund USA
EVP, Chief Regulatory Officer at Vertex
CEO at Stoke Therapeutics
Senior Vice President Value and Access at Biogen
Executive Chairman, Aleta Biotherapeutics
Associate Vice President and Head, Boston Innovation Hub of BD&L Merck Research Laboratories
Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology
Managing Director, American Cancer Society’s BrightEdge Fund
President & CEO of Rhythm Therapeutics
Executive Vice President, R&D and Chief Medical Officer at Sarepta
Partner at McDermott, Quilty & Miller LLP
Head of Global Product Strategy, Oncology, Roche
CEO & Chair at Infinity Pharmaceuticals
Head, Johnson & Johnson Innovation, East North America
Global Head, Pharma R&D Open Innovation, Bayer
Vice President, Government Relations and Public Affairs at Sunovion
President of Minerva Neurosciences
Executive Vice President and Head of Sanofi Genzyme
VP and ERDI Head at Pfizer
Vice-President, Scientific Partnering and Alliances and Site Head, R&D Boston at AstraZeneca
Vice President, U.S. Government Affairs, Alexion Pharmaceuticals, Inc.
Chief Regulatory Officer of Flexion Therapeutics